Oruka Therapeutics MACD Death Cross, Bearish Marubozu on 15-minute chart.

Based on Cross Country's 15-minute chart, which triggered a MACD Death Cross and Bollinger Bands Narrowing at 09/25/2025 14:15, there is a high likelihood of further stock price declines. Additionally, the magnitude of the stock price fluctuations is expected to decrease.

Cross Country Healthcare (CCRN) experienced a 5.5% increase in its stock price on Thursday, September 12, 2025, amidst speculation that it was not the subject of a Federal Trade Commission (FTC) closed-door meeting held on Wednesday. Traders indicated that the real subject of the meeting was likely a lawsuit against Live Nation (LYV) and Ticketmaster, as disclosed on Thursday Cross Country Healthcare gains on speculation it wasn't subject of FTC meeting^[1].

Prior to the meeting, there was speculation that the FTC might be investigating Aya Healthcare's planned $615 million purchase of Cross Country. However, the company disclosed that it had certified compliance with the FTC's second request regarding the deal, indicating substantial progress Cross Country Healthcare gains on speculation it wasn't subject of FTC meeting^[1].

Technical indicators, such as the MACD Death Cross and Bollinger Bands Narrowing, triggered on September 25, 2025, at 14:15, suggest a high likelihood of further stock price declines for Cross Country Healthcare. Additionally, the magnitude of stock price fluctuations is expected to decrease .

The company's stock price performance has been closely monitored by financial analysts, with some upgrading their ratings due to the pending acquisition and compliance with regulatory bodies . However, recent technical indicators point towards a potential downturn, which investors should be aware of.

Investors are advised to stay informed about regulatory developments and technical indicators to make well-informed investment decisions.